Hong Kong-based Akeso has announced that the US Food and Drug Administration (FDA) has approved its PD-1 monoclonal antibody, penpulimab-kcqx, alongside cisplatin or carboplatin and gemcitabine, for ...

USA-based Medicus Pharma (Nasdaq: MDCX) has agreed to acquire UK firm Antev for around $75 million in a share exchange deal.